327 related articles for article (PubMed ID: 14504111)
1. Posttransplantation lymphoproliferative disorders.
Andreone P; Gramenzi A; Lorenzini S; Biselli M; Cursaro C; Pileri S; Bernardi M
Arch Intern Med; 2003 Sep; 163(17):1997-2004. PubMed ID: 14504111
[TBL] [Abstract][Full Text] [Related]
2. Post-transplant lymphoproliferative disorders (PTLD) after solid organ transplantation.
Taylor AL; Marcus R; Bradley JA
Crit Rev Oncol Hematol; 2005 Oct; 56(1):155-67. PubMed ID: 15979320
[TBL] [Abstract][Full Text] [Related]
3. Posttransplantation lymphoproliferative disorders (PTLD): current perspectives.
Nalesnik MA
Semin Thorac Cardiovasc Surg; 1996 Apr; 8(2):139-48. PubMed ID: 8672567
[TBL] [Abstract][Full Text] [Related]
4. Posttransplant lymphoproliferative diseases.
Gross TG; Savoldo B; Punnett A
Pediatr Clin North Am; 2010 Apr; 57(2):481-503, table of contents. PubMed ID: 20371048
[TBL] [Abstract][Full Text] [Related]
5. Management and outcome of liver recipients with post-transplant lymphoproliferative disease.
Glez-Chamorro A; Jimenez C; Moreno-Glez E; Glez-Pinto I; Loinaz C; Gomez R; Garcia I; Alonso O; Palma F; Grande C
Hepatogastroenterology; 2000; 47(31):211-9. PubMed ID: 10690611
[TBL] [Abstract][Full Text] [Related]
6. Initial spontaneous remission of posttransplantation Epstein Barr virus-related B-cell lymphoproliferative disorder of the skin in a renal transplant recipient: case report and review of the literature on cutaneous B-cell posttransplantation lymphoproliferative disease.
Blokx WA; Andriessen MP; van Hamersvelt HW; van Krieken JH
Am J Dermatopathol; 2002 Oct; 24(5):414-22. PubMed ID: 12357204
[TBL] [Abstract][Full Text] [Related]
7. New developments in the diagnosis and management of posttransplantation lymphoproliferative disorders in solid organ transplant recipients.
Preiksaitis JK
Clin Infect Dis; 2004 Oct; 39(7):1016-23. PubMed ID: 15472855
[TBL] [Abstract][Full Text] [Related]
8. Posttransplantation lymphoproliferative disorder in children: clinical, histopathologic, and imaging features.
Pickhardt PJ; Siegel MJ; Hayashi RJ; Kelly M
Radiology; 2000 Oct; 217(1):16-25. PubMed ID: 11012419
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus-specific cytotoxic T-lymphocytes for adoptive immunotherapy of post-transplant lymphoproliferative disease.
Burns DM; Crawford DH
Blood Rev; 2004 Sep; 18(3):193-209. PubMed ID: 15183903
[TBL] [Abstract][Full Text] [Related]
10. Relationship of immunosuppression to Epstein-Barr viral load and lymphoproliferative disease in pediatric heart transplant patients.
Schubert S; Renner C; Hammer M; Abdul-Khaliq H; Lehmkuhl HB; Berger F; Hetzer R; Reinke P
J Heart Lung Transplant; 2008 Jan; 27(1):100-5. PubMed ID: 18187094
[TBL] [Abstract][Full Text] [Related]
11. Persistent increased Epstein-Barr virus loads after solid organ transplantation: truth and consequences?
Green M; Webber SA
Liver Transpl; 2007 Mar; 13(3):321-2. PubMed ID: 17318870
[No Abstract] [Full Text] [Related]
12. Review of Epstein-Barr virus and post-transplant lymphoproliferative disorder post-solid organ transplantation.
Lim WH; Russ GR; Coates PT
Nephrology (Carlton); 2006 Aug; 11(4):355-66. PubMed ID: 16889577
[TBL] [Abstract][Full Text] [Related]
13. New approaches to posttransplant lymphoproliferative disorder (PTLD).
Porcu P
Clin Adv Hematol Oncol; 2005 Jan; 3(1):24-6. PubMed ID: 16166963
[No Abstract] [Full Text] [Related]
14. Primary cutaneous Epstein-Barr virus-related lymphoproliferative disorders in 4 immunosuppressed children.
Wallet-Faber N; Bodemer C; Blanche S; Delabesse E; Eschard C; Brousse N; Fraitag S
J Am Acad Dermatol; 2008 Jan; 58(1):74-80. PubMed ID: 17884243
[TBL] [Abstract][Full Text] [Related]
15. Withdrawal of immunosuppression in liver transplantation: lessons learned from PTLD.
Mazariegos GV
Pediatr Transplant; 2004 Jun; 8(3):210-3. PubMed ID: 15176955
[No Abstract] [Full Text] [Related]
16. [Clinical aspects of Epstein-Barr-virus-associated lymphoproliferative disease].
Kvell K; Balogh P; Németh P
Orv Hetil; 2002 Apr; 143(14):713-9. PubMed ID: 11975391
[TBL] [Abstract][Full Text] [Related]
17. B lymphocytes and Epstein-Barr virus: the lesson of post-transplant lymphoproliferative disorders.
Dolcetti R
Autoimmun Rev; 2007 Dec; 7(2):96-101. PubMed ID: 18035317
[TBL] [Abstract][Full Text] [Related]
18. Occurrence of post-transplant lymphoproliferative disorders among over thousand adult recipients: any role for hepatitis C infection?
Burra P; Buda A; Livi U; Rigotti P; Zanus G; Calabrese F; Caforio A; Menin C; Canova D; Farinati F; Luciana Aversa SM
Eur J Gastroenterol Hepatol; 2006 Oct; 18(10):1065-70. PubMed ID: 16957512
[TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr virus-associated lymphoproliferative disorders.
Rezk SA; Weiss LM
Hum Pathol; 2007 Sep; 38(9):1293-304. PubMed ID: 17707260
[TBL] [Abstract][Full Text] [Related]
20. Brain tumor as an unusual presentation of posttransplant lymphoproliferative disorder.
Azarpira N; Torabineghad S; Rakei M
Exp Clin Transplant; 2009 Mar; 7(1):58-61. PubMed ID: 19364315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
